Aggregate Asset Value: Alcon Inc (ALC)

Corporate emblem and logo of Alcon Inc (ALC)

Alcon Inc. (ALC) is implementing robotic systems and automation for ophthalmic surgery, reducing the human factor during operations. This price chart illustrates total assets, which amount to 31213.59, supported by demand for unique lenses and equipment. A steady cash flow is ensured by regular scheduled procedures and the sale of consumables, confirming the high financial stability of the business.

ALC: alcon.com Aggregate Company Assets 07/04/2022 - 10/28/2026

Financial and market metric breakdowns for Alcon Vision (ALC)

- price and consensus price forecast:
Quote Chart alcon.com|ALC - Analyst Consensus Forecast
- market capitalization data:
Market Value Alcon Corp|ALC - Enterprise Value
- book capitalization data:
Book Value per Share Alcon|ALC - Company Book Value|Market Value to Book Value alcon.com|ALC - Aggregate Company Assets
- debt and liquidity data:
Total Debt to Equity Ratio Alcon Inc.|ALC - Long-Term Debt to Capital|Short-Term Debt to Capital Alcon Corp|ALC - Company Total Debt|Debt to Net Assets Ratio Alcon Corp
Analysis of all company metrics:Alcon Inc.
Manufactured product of Alcon Vision

Innovative ophthalmology solutions from Alcon Inc. (ALC) create a sustainable foundation for business scaling. This total assets chart is based on a reverse calculation via ROA, objectively capturing the sum of capital and liabilities without reporting distortions. Current performance dynamics confirm the effectiveness of investments in therapeutic lines and cataract surgery. Stable asset base growth coupled with maintained profitability confirms the issuer's high investment maturity.

Competing companies

bausch.com (BLCO) - Total Asset Value of Company|GKOS - Company Total Assets|Aggregate Asset Value Apellis Pharmaceuticals, Inc.|Company Total Assets BLTE|Company Total Assets OCUL (Ocular Pharma)|Aggregate Company Assets Harrow, Inc.|viridiantherapeutics.com - Aggregate Asset Value|LENZ: Aggregate Company Assets|OCS - Cumulative Company Assets|EYPT: Company Total Assets|Company Total Assets Kodiak Corp|ALDX - Cumulative Company Assets|Aggregate Asset Value Kala Pharmaceuticals|Opus Genetics Inc - Company Total Assets|Company Assets okyopharma.com OKYO|ADVM: Cumulative Company Assets|Company Assets Outlook Therapeutics Corp OTLK|CLSD (Clearside Biomedical) - Company Total Assets|NBY: Company Assets|kiorapharma.com - Aggregate Company Assets|Alimera Sciences, Inc. (ALIM) - Company Total Asset Base|EYEN (Eyenovia Inc.) - Company Total Assets|Company Total Assets GHSI|Aggregate Company Assets Ocuphire Pharma, Inc. (OCUP)|Aggregate Company Assets opthea.com (OPT)